ArticleOpen forum infectious diseases2025
First Case of Neuroinvasive Oropouche Virus in Wisconsin: A Case Report.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Emerging threat of Oropouche virus: Clinical features, experimental models, and virulence.Virulence · 2026Review
- Response to the Letter by Guagliardo et al.Open forum infectious diseases · 2026Article
- Conserved pathogenesis of ancestral and contemporary Oropouche virus strains in a murine pregnancy model.Nature communications · 2026Article
- The Importance of Public Health and Clinical Context in Investigating and Responding to Cases of Oropouche Virus Disease.Open forum infectious diseases · 2025Article
- Oropouche virus disrupts neurodevelopment and is vertically transmitted.Research square · 2025Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Per the Pan American Health Organization/World Health Organization, Oropouche virus (OROV) is a reemerging arbovirus that poses a yet undetermined degree of threat to the United States, with outbreaks reported in the Caribbean and South America, including new areas of spread, since the end of 2023 and, at this time, there exists no vaccine or disease-specific treatment. Here we describe the presentation and diagnosis of a neuroinvasive case of OROV, the first documented case of OROV in Wisconsin, the first documented case in the United States in 2025, and the first documented US case associated with travel to Panama.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.